JPMORGAN CHASE & CO - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is and the CUSIP is 74366E952. A total of 5 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$6,046,018218,9000.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 12,000$200,1600.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SIMPLEX TRADING, LLC 300$50.00%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders